(818) 356-8248 info@theacrm.com

Nerve Injury

Below is a sample of existing clinical evidence:
“Administration of AFMSCs (Amniotic Fluid-derived Mesenchymal Stem Cells) led to improvements in neurobehavior and expression of regeneration markers. Intravenous administration of AFMSCs may be a promising alternative treatment strategy in peripheral nerve disorder.”

– “Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid–derived mesenchymal stem cells regulated by stromal cell–derived factor-1a in a sciatic nerve injury model,” Yang et al, Journal of Neurosurgery, 2012

For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).

Visit AAICT